Cabergoline treatment in men with psychogenic erectile dysfunction: a randomized, double-blind, placebo-controlled study

被引：0
作者：
M Nickel
D Moleda
T Loew
W Rother
F Pedrosa Gil
机构：
[1] Clinic for Psychosomatic,Department of Psychosomatic Medicine
[2] Inntalklinik,undefined
[3] University Clinic for Psychiatry 1,undefined
[4] PMU,undefined
[5] Regensburg University Clinic,undefined
[6] Psychosomatic Outpatient Clinic,undefined
[7] University Medicine Clinic,undefined
[8] LMU,undefined
来源：
International Journal of Impotence Research | 2007年 / 19卷
关键词：
psychogenic erectile dysfunction; libido; cabergoline; prolactin; testosterone; quality of life;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The effectiveness of cabergoline in 50 men with psychogenic erectile dysfunction was investigated in a 4-month, randomized, placebo-controlled, double-blind study with validated psychological tests, and prolactin, follicle-stimulating hormone, luteinizing hormone and testosterone serum levels. Cabergoline treatment was well-tolerated and resulted in normalization of hormone levels in most cases. In the cabergoline-treated group, significant interactions between prolactin and testosterone serum concentrations were observed. Erectile function improved significantly. Sexual desire, orgasmic function, and the patient's and his partner's sexual satisfaction were also enhanced. Cabergoline may be an effective and safe alternative agent for men with psychogenic ED.
引用
收藏
页码：104 / 107
页数：3
相关论文
共 47 条
[1]  
Cavallero R(2004)Cabergoline treatment of risperidone-induced hyperprolactinemia: a pilot study J Clin Psychiatry 65 187-190
[2]  
Cocchi F(2003)Effects of acute prolactin manipulation on sexual drive and function in males J Endocrinol 179 357-365
[3]  
Angelone SM(2002)Cabergoline can increase penile erections and libido Neurology 58 831-625
[4]  
Lattuada E(2004)Six months of treatment with cabergoline restores sexual potency in hyperprolactinemic males: an open longitudinal study monitoring nocturnal penile tumescence J Clin Endocrinol Metab 89 621-197
[5]  
Smeraldi E(2003)Validation of the German version of the International Index of Erectile Function (IIEF) in patients with erectile dysfunction, Peyronie's disease and controls Int J Impot Res 15 192-296
[6]  
Krueger THC(1976)Development of a rating scale for primary depressive illness Br J Soc Clin Psychol 6 278-55
[7]  
Haake P(1959)The assessment of anxiety states by rating Br J Med Psychol 32 50-217
[8]  
Haverkamp J(2002)The effect of erectile dysfunction on quality of life: psychometric testing of a new quality of life measure for patients with erectile dysfunction J Urol 167 212-117
[9]  
Kramer M(1997)Construction of scales for the Center for Marital and Sexual Health (CMASH). Sexual Functionning Questionnaire J Sex Marital Ther 23 103-82
[10]  
Exton MS(2003)Hyperprolactinemia in men Endocrine 20 75-116
12345